Merit Medical Systems Shareholders Approve Key Proposals

Merit Medical Systems ( (MMSI) ) has shared an update.

On May 14, 2025, Merit Medical Systems, Inc. held its Annual Meeting of Shareholders where shareholders voted on key proposals including the election of four directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as the independent public accounting firm for 2025. All proposals were approved, indicating shareholder support for the company’s leadership and strategic direction.

The most recent analyst rating on (MMSI) stock is a Buy with a $93.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.

Spark’s Take on MMSI Stock

According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.

Merit Medical Systems receives an overall score of 70, reflecting strong financial performance and positive earnings call insights. However, the high P/E ratio and technical resistance suggest cautious optimism. The company’s robust revenue growth and improved margins are key strengths, while managing leverage and tariff impacts will be crucial for future performance.

To see Spark’s full report on MMSI stock, click here.

More about Merit Medical Systems

Merit Medical Systems, Inc. operates in the medical device industry, focusing on the development and manufacturing of disposable medical devices used in interventional, diagnostic, and therapeutic procedures, with a market focus on improving patient care and outcomes.

Average Trading Volume: 787,076

Technical Sentiment Signal: Buy

Current Market Cap: $5.84B

For detailed information about MMSI stock, go to TipRanks’ Stock Analysis page.